E I D Parry India (EIDPARRY) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
13 Nov, 2026Executive summary
Q2 FY27 consolidated revenue was INR 11,213 crore vs INR 10,462 crore; EBITDA was INR 995 crore vs INR 1,291 crore, and profit attributable to owners was INR 253 crore vs INR 424 crore.
Sugar & Biofuels recovered with higher sugar volumes and realisations, improved distillery volumes and disciplined costs; Nutraceuticals profitability rose multi-fold YoY.
Priorities include higher-value growth, operating discipline, cost and cash management, and stronger capabilities across businesses.
Financial highlights
H1 FY27 consolidated revenue was INR 20,166 crore vs INR 18,279 crore; EBITDA was INR 1,772 crore vs INR 2,158 crore, and profit attributable to owners was INR 394 crore vs INR 671 crore.
Standalone Q2 revenue was INR 860 crore vs INR 748 crore; operational EBITDA loss narrowed to INR 8 crore from INR 36 crore.
Standalone H1 revenue was INR 1,593 crore vs INR 1,504 crore; operational EBITDA loss narrowed to INR 36 crore from INR 57 crore.
Standalone Q2 loss after tax was INR 22 crore vs INR 286 crore; the prior-year loss included net exceptional impairment/reversal items of INR 352 crore.
Consolidated H1 net cash from operating activities was INR 584.93 crore; net cash used in financing was INR 1,425.98 crore.
Outlook and guidance
H2 priorities include accelerating digital interventions, monitoring policy and market developments, and strengthening leadership, critical capabilities and accountability.
Jaggery facility commissioning is expected by Q4 FY27, one quarter later than planned due to statutory approval delays; farmer engagement programs have intensified, with benefits expected in cane yields and recovery.
A proposal to sell the Sivagangai Distillery Unit as a going concern was approved on November 13, after the reporting date; it is a non-adjusting event for Q2 results.
A voluntary separation scheme was approved for employees at one plant on August 12; it was communicated after September 30, so no obligation was recognized at quarter-end.
Latest events from E I D Parry India
- EBITDA fell 42% and PAT 46% on 3% lower revenue, as ethanol policy and climate hit results.EIDPARRY
Q4 23/24 - Revenue up 3%, profit and EBITDA down on higher costs; margin gains in value-added products.EIDPARRY
Q1 26/27 - Revenue up 22% YoY, but profit fell on exceptional items and refinery closure; focus shifts to margin growth.EIDPARRY
Q4 25/26 - Q3 FY26 revenue up 18% YoY; profit after tax at Rs. 232 Cr; segment results mixed.EIDPARRY
Q3 25/26 - H1 FY26 profitability rose on higher realizations and cost control, despite volume pressures.EIDPARRY
Q2 25/26 - Revenue up, profits down; distillery and retail strong, borrowings rise, nutraceuticals weak.EIDPARRY
Q2 24/25 - Q3 FY25 revenue up 12% YoY to ₹8,720 crore; distillery and CPG growth offset sugar pressures.EIDPARRY
Q3 24/25 - Consolidated revenue rose to Rs. 31,609 crore, but impairments led to a standalone PAT loss.EIDPARRY
Q4 24/25 - Improved realizations and distillery gains offset lower volumes; revenue and profit increased.EIDPARRY
Q1 25/26